• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

钆塞酸二钠增强磁共振成像:利用肝脏对比增强指数和肝脾容积比预测肝纤维化分期。

Gd-EOB-DTPA-enhanced MR imaging: prediction of hepatic fibrosis stages using liver contrast enhancement index and liver-to-spleen volumetric ratio.

机构信息

Department of Radiology, Gifu University Hospital, 1-1 Yanagido, 501-1194 Gifu, Japan.

出版信息

J Magn Reson Imaging. 2012 Nov;36(5):1148-53. doi: 10.1002/jmri.23758. Epub 2012 Jul 30.

DOI:10.1002/jmri.23758
PMID:22848019
Abstract

PURPOSE

To develop and evaluate a quantitative parameter for staging hepatic fibrosis by contrast enhancement signal intensity and morphological measurements from gadoxetic acid (Gd-EOB-DTPA)-enhanced MR imaging.

MATERIALS AND METHODS

MR images were obtained in 93 patients; 75 patients had histopathologically proven hepatic fibrosis and 18 patients who had healthy livers were evaluated. The liver-to-muscle signal intensity ratio (SI(post) = SIliver/SImuscle), contrast enhancement index (CEI = SIpost/SIpre), and liver-to-spleen volumetric ratio (VR = Vliver/Vspleen) were evaluated for staging hepatic fibrosis.

RESULTS

VR was most strongly correlated with fibrosis stage (7.21; r = -0.83; P < 0.001). Sensitivity, specificity, and area under the ROC curve demonstrated by linear regression formula generated by VR and CEI in predicting fibrous scores were 100%, 73%, and 0.91, respectively, for the detection of hepatic fibrosis F1 or greater (≥ F1),100%, 87%, and 0.96 for ≥ F2, 74%, 98%, and 0.93 for ≥ F3 and 91%, 100%, and 0.97 for F4.

CONCLUSION

The liver-to-spleen volumetric ratio and contrast enhancement index were reliable biomarkers for the staging of hepatic fibrosis on Gd-EOB-DTPA-enhanced MR imaging.

摘要

目的

通过钆塞酸(Gd-EOB-DTPA)增强磁共振成像的对比增强信号强度和形态学测量,开发和评估一种用于肝纤维化分期的定量参数。

材料与方法

对 93 例患者进行了磁共振成像检查;75 例患者经组织病理学证实患有肝纤维化,18 例肝脏健康的患者作为对照。评估了肝-肌肉信号强度比(SI(post) = SIliver/SImuscle)、对比增强指数(CEI = SIpost/SIpre)和肝-脾容积比(VR = Vliver/Vspleen),用于分期肝纤维化。

结果

VR 与纤维化分期相关性最强(7.21;r = -0.83;P < 0.001)。由 VR 和 CEI 生成的线性回归公式预测纤维评分时,VR 和 CEI 对肝纤维化 F1 或更高阶段(≥ F1)的检测具有 100%的敏感性、73%的特异性和 0.91 的ROC 曲线下面积,对≥ F2 的检测具有 100%的敏感性、87%的特异性和 0.96 的ROC 曲线下面积,对≥ F3 的检测具有 74%的敏感性、98%的特异性和 0.93 的ROC 曲线下面积,对 F4 的检测具有 91%的敏感性、100%的特异性和 0.97 的ROC 曲线下面积。

结论

在 Gd-EOB-DTPA 增强磁共振成像上,肝-脾容积比和对比增强指数是肝纤维化分期的可靠生物标志物。

相似文献

1
Gd-EOB-DTPA-enhanced MR imaging: prediction of hepatic fibrosis stages using liver contrast enhancement index and liver-to-spleen volumetric ratio.钆塞酸二钠增强磁共振成像:利用肝脏对比增强指数和肝脾容积比预测肝纤维化分期。
J Magn Reson Imaging. 2012 Nov;36(5):1148-53. doi: 10.1002/jmri.23758. Epub 2012 Jul 30.
2
Hepatic parenchymal enhancement at Gd-EOB-DTPA-enhanced MR imaging: correlation with morphological grading of severity in cirrhosis and chronic hepatitis.钆塞酸二钠增强磁共振成像时的肝实质增强:与肝硬化和慢性肝炎严重程度的形态学分级的相关性。
Magn Reson Imaging. 2012 Apr;30(3):356-60. doi: 10.1016/j.mri.2011.11.002. Epub 2012 Jan 5.
3
Clinical and histologic implications of delayed hepatobiliary enhancement on magnetic resonance imaging with gadolinium ethoxybenzyl diethylenetriaminepentaacetic Acid.钆喷替酸葡甲胺磁共振成像肝胆期延迟增强的临床和组织学意义。
Invest Radiol. 2012 Nov;47(11):649-55. doi: 10.1097/RLI.0b013e3182652fb9.
4
Staging liver fibrosis by using liver-enhancement ratio of gadoxetic acid-enhanced MR imaging: comparison with aspartate aminotransferase-to-platelet ratio index.使用钆塞酸增强磁共振成像的肝增强率对肝纤维化进行分期:与天门冬氨酸氨基转移酶/血小板比值指数的比较。
Magn Reson Imaging. 2011 Oct;29(8):1047-52. doi: 10.1016/j.mri.2011.05.007. Epub 2011 Jul 19.
5
Comparison of magnetic resonance elastography and gadoxetate disodium-enhanced magnetic resonance imaging for the evaluation of hepatic fibrosis.磁共振弹性成像与钆塞酸二钠增强磁共振成像在肝纤维化评估中的比较。
Invest Radiol. 2013 Aug;48(8):607-13. doi: 10.1097/RLI.0b013e318289ff8f.
6
New proposal for the staging of nonalcoholic steatohepatitis: evaluation of liver fibrosis on Gd-EOB-DTPA-enhanced MRI.非酒精性脂肪性肝炎分期的新建议:钆塞酸二钠增强 MRI 评估肝纤维化。
Eur J Radiol. 2010 Jan;73(1):137-42. doi: 10.1016/j.ejrad.2008.09.036. Epub 2008 Nov 20.
7
Gd-EOB-DTPA-enhanced MR imaging: evaluation of hepatic enhancement effects in normal and cirrhotic livers.钆塞酸二钠增强磁共振成像:评估正常和肝硬化肝脏的肝增强效果。
Eur J Radiol. 2011 Dec;80(3):e311-6. doi: 10.1016/j.ejrad.2011.01.020. Epub 2011 Feb 18.
8
Staging hepatic fibrosis: comparison of gadoxetate disodium-enhanced and diffusion-weighted MR imaging--preliminary observations.钆塞酸二钠增强与弥散加权磁共振成像在肝纤维化分期中的比较:初步观察。
Radiology. 2011 Apr;259(1):142-50. doi: 10.1148/radiol.10100621. Epub 2011 Jan 19.
9
Spleen size measured on enhanced MRI for quantitatively staging liver fibrosis in minipigs.增强 MRI 测量脾脏大小用于定量分期小型猪肝纤维化。
J Magn Reson Imaging. 2013 Sep;38(3):540-7. doi: 10.1002/jmri.24007. Epub 2013 Jan 24.
10
Contrast enhanced liver MRI in patients with primary sclerosing cholangitis: inverse appearance of focal confluent fibrosis on delayed phase MR images with hepatocyte specific versus extracellular gadolinium based contrast agents.原发性硬化性胆管炎患者的磁共振胆胰管成像:与细胞外钆基对比剂相比,肝特异性对比剂延迟相 MR 图像上局灶融合性纤维化为反转表现。
Acad Radiol. 2011 Dec;18(12):1549-54. doi: 10.1016/j.acra.2011.08.007. Epub 2011 Sep 29.

引用本文的文献

1
Hepatocyte uptake ratio derived from T1 mapping for quantitative assessment of liver fibrosis.基于T1映射的肝细胞摄取率用于肝纤维化的定量评估。
Eur Radiol. 2025 Jul 30. doi: 10.1007/s00330-025-11842-4.
2
Modeling Liver Fibrosis Progression in Patients With Viral Hepatitis Using the Machine Learning Tool Subtype and Stage Inference (SuStaIn).使用机器学习工具亚型和阶段推断(SuStaIn)对病毒性肝炎患者的肝纤维化进展进行建模。
Cureus. 2025 Feb 8;17(2):e78744. doi: 10.7759/cureus.78744. eCollection 2025 Feb.
3
MR elastography vs a combination of common non-invasive tests for estimation of severe liver fibrosis in patients with hepatobiliary tumors.
磁共振弹性成像与常见非侵入性检查组合用于评估肝胆肿瘤患者严重肝纤维化的比较
Eur Radiol. 2025 Mar;35(3):1464-1472. doi: 10.1007/s00330-024-11086-8. Epub 2024 Sep 30.
4
The impact of hepatic and splenic volumetric assessment in imaging for chronic liver disease: a narrative review.肝脏和脾脏容积评估在慢性肝病影像学检查中的影响:一项叙述性综述
Insights Imaging. 2024 Jun 18;15(1):146. doi: 10.1186/s13244-024-01727-3.
5
Multiparametric MRI combined with liver volume for quantitative evaluation of liver function in patients with cirrhosis.多参数 MRI 结合肝体积定量评估肝硬化患者肝功能。
Diagn Interv Radiol. 2022 Nov;28(6):547-554. doi: 10.5152/dir.2022.211325.
6
Magnetic Resonance Imaging of Liver Fibrosis, Fat, and Iron.肝脏纤维化、脂肪和铁的磁共振成像。
Radiol Clin North Am. 2022 Sep;60(5):705-716. doi: 10.1016/j.rcl.2022.04.003. Epub 2022 Jul 15.
7
Gadoxetic acid-enhanced magnetic resonance imaging predicts hyperbilirubinemia induced by glecaprevir during hepatitis C virus treatment.钆塞酸增强磁共振成像预测丙型肝炎病毒治疗期间格卡瑞韦引起的高胆红素血症。
Sci Rep. 2022 May 12;12(1):7847. doi: 10.1038/s41598-022-11707-6.
8
The Efficiency of Fractional Anisotropy, Apparent Diffusion Coefficient, and Contrast Enhancement Index in Liver Fibrosis Staging.分数各向异性、表观扩散系数和对比增强指数在肝纤维化分期中的效能
Sisli Etfal Hastan Tip Bul. 2022 Mar 28;56(1):113-118. doi: 10.14744/SEMB.2021.33396. eCollection 2022.
9
A novel index for staging hepatitis B related liver cirrhosis in patients with hepatocellular carcinoma.一种用于分期乙型肝炎相关肝硬化的新型指标在肝细胞癌患者中的应用。
Sci Prog. 2021 Apr-Jun;104(2):368504211018052. doi: 10.1177/00368504211018052.
10
Can gadoxetic acid-enhanced magnetic resonance imaging be used to avoid liver biopsy in patients with nonalcoholic fatty liver disease?钆塞酸二钠增强磁共振成像能否用于避免非酒精性脂肪性肝病患者的肝活检?
World J Hepatol. 2020 Sep 27;12(9):661-671. doi: 10.4254/wjh.v12.i9.661.